BPMX News and Press, BioPharmX Corporation. Common

CAMPBELL, Calif. , May 15, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX" or the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that, in anticipation of closing its merger with Ti...

Are These On Your List Of Penny Stocks To Watch? If you’re looking for some penny stocks to watch today, it’s important to understand certain trends. For instance, countless stocks under $5 have made huge moves this year thanks to COVID-19. However, not all penny stocks deali...

BioPharmX (NYSEMKT: BPMX ) stockholders have voted in favor of its merger with privately held Timber Pharmaceuticals. The combined company will do business as Timber Pharmaceuticals with shares trading on the NYSE under the ticker "TMBR." More news on: BioPharmX Corporation, Healthcare s...

CAMPBELL, Calif. , May 13, 2020 /PRNewswire/ --  BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") today announced that all proposals related to its proposed merger with Timber Pharmaceuticals LLC ("Timber") were approved by BioPharmX's stockholders at a special meeting he...

WOODCLIFF LAKE, N.J. , May 12, 2020 /PRNewswire/ -- Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced its support for Ichthyosis Awareness ...

CAMPBELL, Calif., May 8, 2020 /PRNewswire/ --  BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC ("Timber") and related matters as described in the proxy statemen...

CAMPBELL, Calif. , April 27, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX)  ("BioPharmX") today announced that the date of its special stockholders' meeting to consider and vote on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC ("Timber") and r...

WOODCLIFF LAKE, N.J. , April 6, 2020 /PRNewswire/ -- Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced the company has been awarded the sec...

CAMPBELL, Calif. , March 25, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, received notification on March 24, 2020 from the NYSE American LLC (the "NYSE ...

REHOVOT, Israel, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously approved drugs for Parkinson disease, announced today the appointment of David S. Tierney M.D. as Chief Executive Officer, effective imm...